• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的长期结节病中的骨质流失。

Bone loss in untreated longstanding sarcoidosis.

作者信息

Montemurro L, Fraioli P, Rizzato G

机构信息

Sarcoidosis Clinic, Niguarda Hospital, Milan, Italy.

出版信息

Sarcoidosis. 1991 Mar;8(1):29-34.

PMID:1669936
Abstract

The introduction of new techniques for the study of Bone Mineral Content (BMC) has not yet been extensively applied to sarcoidosis. Using Quantitative Computed Tomography (QCT) in a long-term prednisone-treated sarcoid population we have shown in 1988 [1] that Bone Mineral Loss is more frequent than elsewhere reported with other techniques on patients with different diseases. It was not clear if this difference was due to the sarcoidosis itself or to the better sensitivity of QCT compared to former techniques [2]. Thus we have now studied QCT in a group of 36 untreated patients with active, histologically proven sarcoidosis, chronic in most cases, to clarify the action of sarcoidosis itself over the BMC. For each patient Vertebral Cancellous Mineral Content (VCMC) has been expressed in terms of Z score (i.e. the number of Standard Deviations (SD) above or below the normal value) in order to overcome the differences due to age and sex. In the whole group, mean value of Z score was -0.41 +/- 0.30 (P > 0.05 vs. 190 normals). Nevertheless VCMC was below the normal range in 13 out of 36 patients; in five of them, all with longstanding sarcoidosis for at least 2 years, VCMC was more than two SD below the normal; four out of 36 had a VCMC lower than 110 mg/cm3 K2HPO4 eq, that is considered the threshold level under which the risk of fracture begins (but three of them were postmenopausal females).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

骨矿物质含量(BMC)研究新技术的引入尚未广泛应用于结节病。1988年我们在长期接受泼尼松治疗的结节病患者群体中使用定量计算机断层扫描(QCT)[1]发现,骨矿物质流失比其他技术在不同疾病患者中报道的更为常见。尚不清楚这种差异是由于结节病本身,还是由于QCT比以前的技术具有更高的敏感性[2]。因此,我们现在对一组36例未经治疗的、组织学确诊为活动性结节病(大多数为慢性)的患者进行了QCT研究,以阐明结节病本身对BMC的影响。为了克服年龄和性别差异,对每位患者的椎体松质骨矿物质含量(VCMC)用Z评分表示(即高于或低于正常值的标准差(SD)数)。在整个组中,Z评分的平均值为-0.41±0.30(与190名正常人相比,P>0.05)。然而,36例患者中有13例的VCMC低于正常范围;其中5例,均患有至少2年的长期结节病,VCMC比正常低两个以上标准差;36例中有4例的VCMC低于110mg/cm³K₂HPO₄当量,这被认为是骨折风险开始的阈值水平(但其中3例是绝经后女性)。(摘要截断于250字)

相似文献

1
Bone loss in untreated longstanding sarcoidosis.未经治疗的长期结节病中的骨质流失。
Sarcoidosis. 1991 Mar;8(1):29-34.
2
Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women.泼尼松诱发的结节病骨质流失:一种在绝经后女性中尤为常见的风险。
Sarcoidosis. 1988 Sep;5(2):93-8.
3
Researching osteoporosis in prednisone treated sarcoid patients.研究泼尼松治疗的结节病患者中的骨质疏松症。
Sarcoidosis. 1987 Mar;4(1):45-8.
4
Bone mineral density in women with sarcoidosis.结节病女性的骨矿物质密度
J Bone Miner Metab. 2004;22(1):48-52. doi: 10.1007/s00774-003-0448-0.
5
Bone loss in prednisone treated sarcoidosis: a two-year follow-up.泼尼松治疗结节病中的骨质流失:两年随访
Ann Ital Med Int. 1990 Jul-Sep;5(3 Pt 1):164-8.
6
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.终末期肺病肺移植候选者中的骨质疏松症
Am J Med. 1996 Sep;101(3):262-9. doi: 10.1016/S0002-9343(96)00155-6.
7
Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.鲑鱼降钙素(sCT)在慢性结节病长期类固醇治疗中对骨骼的保护作用。
Sarcoidosis. 1988 Sep;5(2):99-103.
8
Lactose intolerance: a risk factor for reduced bone mineral density and vertebral fractures?乳糖不耐受:骨密度降低和椎体骨折的一个风险因素?
J Gastroenterol. 2002;37(12):1014-9. doi: 10.1007/s005350200171.
9
Influence of number of pregnancies on bone mineral density in postmenopausal women of different age groups.不同年龄组绝经后女性怀孕次数对骨密度的影响。
J Bone Miner Metab. 2003;21(4):234-41. doi: 10.1007/s00774-003-0415-9.
10
[Mineral content in bones of children with symptomless celiac disease and gluten-free diet].[无症状乳糜泻患儿骨骼中的矿物质含量与无麸质饮食]
Orv Hetil. 1997 Dec 21;138(51):3233-8.

引用本文的文献

1
Osteoporosis and major fragility fractures (MOF) in sarcoidosis patients: association with disease severity.结节病患者的骨质疏松症和主要脆性骨折(MOF):与疾病严重程度相关。
Aging Clin Exp Res. 2023 Dec;35(12):3015-3022. doi: 10.1007/s40520-023-02589-3. Epub 2023 Nov 4.
2
Bone fragility and sarcoidosis: An underestimated relationship.骨脆性与结节病:一种被低估的关系。
Front Med (Lausanne). 2022 Nov 17;9:1026028. doi: 10.3389/fmed.2022.1026028. eCollection 2022.
3
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
系统性糖皮质激素的使用与类肉瘤病患者发生主要骨质疏松性骨折的风险。
Osteoporos Int. 2017 Oct;28(10):2859-2866. doi: 10.1007/s00198-017-4115-z. Epub 2017 Jun 21.
4
Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.结节病患者椎骨和非椎骨骨折的风险:一项基于人群的队列研究。
Osteoporos Int. 2016 Apr;27(4):1603-1610. doi: 10.1007/s00198-015-3426-1. Epub 2015 Dec 2.
5
Bone density is normal and does not change over 2 years in sarcoidosis.结节病患者的骨密度正常,且在两年内无变化。
Osteoporos Int. 2015 Feb;26(2):611-6. doi: 10.1007/s00198-014-2870-7. Epub 2014 Aug 30.
6
Randomised controlled trial of vitamin D supplementation in sarcoidosis.随机对照试验维生素 D 补充剂治疗结节病。
BMJ Open. 2013 Oct 23;3(10):e003562. doi: 10.1136/bmjopen-2013-003562.
7
Calcium and vitamin D in sarcoidosis: how to assess and manage.结节病中的钙和维生素 D:如何评估和管理。
Semin Respir Crit Care Med. 2010 Aug;31(4):474-84. doi: 10.1055/s-0030-1262215. Epub 2010 Jul 27.
8
Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study.结节病患者骨矿物质密度未变但出现进行性椎体畸形:一项4年随访研究
Osteoporos Int. 2008 Jun;19(6):839-47. doi: 10.1007/s00198-007-0513-y.
9
Clinical impact of bone and calcium metabolism changes in sarcoidosis.结节病中骨与钙代谢变化的临床影响
Thorax. 1998 May;53(5):425-9. doi: 10.1136/thx.53.5.425.
10
Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.用鲑鱼降钙素预防结节病患者皮质类固醇诱导的骨质疏松症。
Calcif Tissue Int. 1991 Aug;49(2):71-6. doi: 10.1007/BF02565124.